KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:ARGS
Delisted

Argos Therapeutics Fund Price (Quote)

NASDAQ Stock Exchange
Open Broker Account
$0.0536
+0 (+0%)
At Close: Apr 15, 2020
Forecast Signals Historical Prices Predictions Profile

Range Low Price High Price Comment
30 days $0.0536 $0.0536 Wednesday, 15th Apr 2020 ARGS stock ended at $0.0536. During the day the stock fluctuated 0% from a day low at $0.0536 to a day high of $0.0536.
90 days $0.0536 $0.0536
52 weeks $0.0350 $0.0840

Historical Argos Therapeutics prices

Date Open High Low Close Volume
Jun 28, 2019 $0.0459 $0.0649 $0.0459 $0.0649 13 516
Jun 27, 2019 $0.0680 $0.0680 $0.0680 $0.0680 46
Jun 26, 2019 $0.0459 $0.0699 $0.0459 $0.0680 24 580
Jun 25, 2019 $0.0687 $0.0687 $0.0460 $0.0460 1 426
Jun 24, 2019 $0.0500 $0.0699 $0.0460 $0.0699 37 598
Jun 21, 2019 $0.0501 $0.0700 $0.0501 $0.0700 2 951
Jun 20, 2019 $0.0601 $0.0700 $0.0501 $0.0700 1 253
Jun 19, 2019 $0.0700 $0.0700 $0.0700 $0.0700 68
Jun 18, 2019 $0.0650 $0.0700 $0.0600 $0.0700 593
Jun 17, 2019 $0.0458 $0.0700 $0.0458 $0.0700 12 853
Jun 14, 2019 $0.0520 $0.0700 $0.0520 $0.0700 1 602
Jun 13, 2019 $0.0579 $0.0700 $0.0579 $0.0680 14 552
Jun 12, 2019 $0.0600 $0.0600 $0.0600 $0.0600 16
Jun 11, 2019 $0.0457 $0.0680 $0.0454 $0.0600 61 966
Jun 10, 2019 $0.0680 $0.0680 $0.0455 $0.0567 15 141
Jun 07, 2019 $0.0452 $0.0785 $0.0452 $0.0467 2 840
Jun 06, 2019 $0.0452 $0.0785 $0.0451 $0.0785 1 279
Jun 05, 2019 $0.0452 $0.0783 $0.0450 $0.0690 16 425
Jun 04, 2019 $0.0785 $0.0785 $0.0785 $0.0785 75
Jun 03, 2019 $0.0620 $0.0785 $0.0620 $0.0785 1 645
May 31, 2019 $0.0400 $0.0790 $0.0400 $0.0790 45 877
May 30, 2019 $0.0790 $0.0790 $0.0401 $0.0790 2 388
May 29, 2019 $0.0595 $0.0725 $0.0403 $0.0700 20 431
May 28, 2019 $0.0402 $0.0790 $0.0402 $0.0790 16 347
May 24, 2019 $0.0570 $0.0790 $0.0402 $0.0790 24 034
Click to get the best stock tips daily for free!

About Argos Therapeutics

Argos Therapeutics, Inc. focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on Arcelis, its proprietary technology platform. Its development stage products include AGS-003, which is under Phase III clinical trials for the treatment of metastatic renal cell carcinoma and other cancers; and AGS-004, which ... ARGS Profile

Golden Star

Ticker Date Change Price
DHT Apr 24 2.04% $11.28
MLI Apr 19 9.66% $52.28
LPLA Apr 19 1.42% $262.59
DOOR Apr 18 0.167% $131.39
LNG Apr 17 1.49% $156.81
FCN Apr 16 1.80% $207.62
ELV Apr 16 5.97% $506.97
AKR Apr 05 4.78% $16.53
ITCI Apr 05 7.04% $68.44
VSTS Apr 04 0.425% $18.82
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT